Cargando…
Pembrolizumab-induced autoimmune Stevens-Johnson syndrome/toxic epidermal necrolysis with myositis and myocarditis in a patient with esophagogastric junction carcinoma: a case report
Immune checkpoint inhibitors (ICIs) have significantly improved outcomes for cancer patients. With the widespread clinical application of ICIs, their adverse reactions have gradually been recognized. The side effects of ICIs are generally less severe than those of chemotherapy. However, some adverse...
Autores principales: | Cao, Jiashun, Li, Qiu, Zhi, Xiuyi, Yang, Fan, Zhu, Weipeng, Zhou, Ting, Hou, Xianming, Chen, Donghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798481/ https://www.ncbi.nlm.nih.gov/pubmed/35116686 http://dx.doi.org/10.21037/tcr-21-470 |
Ejemplares similares
-
Toxic epidermal necrolysis and Stevens-Johnson syndrome
por: Harr, Thomas, et al.
Publicado: (2010) -
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
por: Klimas, Natasha, et al.
Publicado: (2015) -
Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
por: Vivar, Karina L., et al.
Publicado: (2017) -
The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
por: Yang, Shang-Chen, et al.
Publicado: (2018) -
Ampicillin/sulbactam: Stevens-Johnson syndrome/toxic epidermal necrolysis
Publicado: (2021)